ReviewBMC pediatrics2025
Incomplete Kawasaki disease presenting primarily with cough: a case report and brief literature review.
Review in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKawasaki disease (KD) is an acute systemic vasculitis predominantly affecting children under 5 years of age. To prevent the development of cardiac aneurysms and their associated adverse outcomes, such as coronary artery dissection with subsequent bleeding, early recognition and treatment are of utmost importance. The classic early symptoms of KD include fever, conjunctival congestion, cracked lips, and others. However, these symptoms are not exclusive to KD and can also be observed in a variety of infectious diseases. Peeling of the skin on the hands, feet, fingers, and around the anus typically becomes evident around ten days after the onset of the disease or even later. Once complications occur, treatment may be ineffective. Hence, early diagnosis and timely treatment are essential to control disease progression, prevent further exacerbation of complications, and promote rapid lesion recovery. CASE PRESENTATION: A 3-year-old boy initially presented solely with sever cough symptoms, followed by fever, which are typical manifestations of a respiratory illness. Additionally, conjunctival hemorrhage developed during the course of the illness. Laboratory tests showed significant elevation in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Despite anti-infective treatment with ceftriaxone, the condition did not improve. The clinical presentation and laboratory findings were consistent with a diagnosis of incomplete Kawasaki disease (IKD). Immediately after treatment with intravenous immunoglobulin (IVIG) and aspirin, the patient's fever and cough symptoms subsided within the next two days. Cardiac ultrasonography at the time of discharge indicated that the coronary artery had healed. At the 1-month and 3-month follow-ups, the patient was in good general health.
conclusionsIt is uncommon for a patient with Kawasaki disease (KD) to initially present with a severe cough as the predominant symptom, especially in the absence of other classic clinical features and with poor response to anti-infective therapy. Therefore, in such cases, clinicians should maintain a high index of suspicion for incomplete Kawasaki disease (IKD) and promptly conduct coronary artery evaluations to avoid delays in diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.